Search Results 1511-1520 of 13118 for transexamic

  1. Publications - Leigh G. Griffiths, Ph.D., MRCVS - Mayo Clinic

    Wu J, Deng J, Theocharidis G, Sarrafian TL, Griffiths LG, Bronson RT, Veves A, Chen J, Yuk H, Zhao X. Author Correction: Adhesive anti-fibrotic interfaces ...

  2. Mayo researchers say oral apixaban safe and effective for treating blood clots in cancer patients

    SAN DIEGO — Mayo Clinic researchers have found that an oral drug, apixaban, used to treat blood clots in patients undergoing cancer therapy, is safe and ...

  3. Patient Stories - Francis A. Farraye, M.D., M.S. - Mayo Clinic

    Have 2X the impact! ... Make a gift that can go twice as far to advance healthcare research. Give Today.

  4. Digestive Diseases Update

    2022 Issues · The Role of Capsule Endoscopy in Diagnosis and Management of Inflammatory Bowel Disease · Examining the Clinical Presentation and Imaging ...

  5. Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - Mayo Clinic

    This is a multicenter, randomized (1:1; oral treprostinil to placebo), double-blind, placebo-controlled study in subjects with World Health Organization (WHO) ...

  6. Publications - Anteneh M. Feyissa, M.D. - Mayo Clinic

    Freund BE, Shourav MMI, Feyissa AM, Meschia JF, Yonas A, Barrett KM, Tatum WO, Lin MP. Seizures in Cerebral Amyloid Angiopathy: A Systematic Review and ...

  7. Publications - K Robert Shen, M.D. - Mayo Clinic

    Rocco R, Hendriksen BS, Ortiz BA, Shen KR, Cassivi SD, Saddoughi S, Reisenauer JS, Wigle DA, Tapias LF. Impact of lymph node evaluation standard in patients ...

  8. Biological Therapy For Cancer Clinical Trials - Mayo Clinic Research

    Epacadostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving pembrolizumab and epacadostat may work better in ...

  9. CorMatrix ECM Tricuspid Valve Replacement - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Intravesical Administration of INSTILADRIN (rAd-IFN With Syn3) in Patients With Bladder Cancer - Mayo Clinic

    rAd-IFN is a non-replicating recombinant adenovirus type 5 (Ad5)-vector encoding the interferon alpha-2b (IFNα2b) gene. Syn 3 is clinical surfactant excipient ...